65,437 trials
Pancreatic Adenocarcinoma
Primary: Progression-free Survival (PFS) — 111; 169; 183 days
Respiratory Distress Syndrome
Primary: The Primary Objective of the Study is to Compare Between the Two Groups, the Number of Subjects Alive and Extubated at 48 Hours Post Surfactant Administration…
COPD · Interstitial Lung Disease
Primary: Change in FEV1 From Baseline Among COPD Patients — 12.8 percentage of change in FEV1
Alzheimer's Disease Psychosis
Primary: Antipsychotic Efficacy — -1.93; -3.76 Score on the NPI-NH scale — p=0.0451
Type 1 Diabetes
Primary: Average Blood Glucose Over the Closed-loop Control Period — 164 mg/dl
Cocaine Dependence · Depression
Primary: Cocaine Abstinence During Last Three Weeks of Study — 5; 9 participants
Dry Eye Syndrome · Keratoconjunctivitis Sicca
Primary: Tear Meniscus Height Captured by Optical Coherence Tomography — 238.4; 634.9 µm
Food Allergy
Primary: Desensitization Measured by Proportion of Food Allergic (FA) Participants Who Pass a DBPCFC to 2,000 mg Protein for Each of 2 Allergens at Week 36 — 30; 4 Participants
Cesarean Section
Primary: Verbal Pain Score With Movement — 1.92; 1.50 units on a scale
Disorder Related to Lung Transplantation · Bronchiolitis Obliterans · Decreased Immunologic Activity
Primary: Number Of Participants With Chronic Rejection Who Met Primary Combined End-point — 2; 5 Participants — p=0.03
Non-Small Cell Lung Cancer
Primary: Percentage of Participants With Stable Disease (SD) or Objective Response (Complete and Partial Response [CR + PR] According to Response Evaluation Criteria in Solid…
HIV Infections
Primary: Percentage of Participants With Plasma HIV-1 RNA <50 c/mL at Week 48 Using Snapshot Algorithm — 94; 94 Percentage of participants
The Skeletal Effects of SSRIs
Primary: Total Body Less Head Bone Mineral Content (TBLH BMC) Z-score (Adjusted for Age-sex-height-race) — 0.35; 0.43; 0.36; 0.44 Z score (age-sex-height-race specific)
Brain and Central Nervous System Tumors · Extragonadal Germ Cell Tumor · Ovarian Cancer
Primary: Rate of Complete Response — 38; 7; 11 Participants
Diabetes Mellitus, Type 2
Primary: Change From Baseline to 24 Weeks in Hemoglobin A1c (HbA1c) — -1.25; -1.22 Percentage of glycosylated hemoglobin — p=0.693